Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain - Related Studies

Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain

This study is ongoing, but not recruiting participants.

Study NCT00025311. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Metastatic Cancer

2	Additional conditions recognized in this trial
		Neoplasm Metastasis

3	More general conditions related to this trial
		Neoplasms
		Neoplastic Processes
		Pathologic Processes

4	Interventions listed in this trial
		topotecan hydrochloride

5	Additional drug interventions recognized in this trial
		Topotecan

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		New York University School of Medicine
		National Cancer Institute (NCI)